Publication Name	World Journal of Stem Cells
Manuscript ID	58309
Country	China

Received	2020-08-08 03:05
Peer-Review Started	2020-07-17 06:15
To Make the First Decision
Return for Revision	2020-10-21 19:59
Revised	2020-12-03 03:30
Second Decision	2020-12-25 09:04
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2020-12-28 03:50
Articles in Press	2020-12-28 03:50
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-02-22 06:54
Publish the Manuscript Online	2021-02-24 03:29

ISSN	1948-0210 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Respiratory System
Manuscript Type	Minireviews
Article Title	Targeting mesenchymal stem cell therapy for severe pneumonia patients
Manuscript Source	Invited Manuscript
All Author List	Guy Lam, Yuan Zhou, Jia-Xian Wang and Yat-Ping Tsui
ORCID	Author(s) ORCID Number Guy Lam http://orcid.org/0000-0002-6184-304X Yuan Zhou http://orcid.org/0000-0002-6796-9153 Jia-Xian Wang http://orcid.org/0000-0002-9056-9879 Yat-Ping Tsui http://orcid.org/0000-0002-4612-7416
Funding Agency and Grant Number	Funding Agency Grant Number Project Contract for Technical Innovation Project for Small and Medium-sized Science and Technology Enterprises in Jiangning District 2020JSCX0563
Corresponding Author	Yat-Ping Tsui, PhD, Director, Director, Research & Development, Help Therapeutics Co. Ltd., No. 568 Longmian Avenue, Jiangning District, Nanjing 211100, Jiangsu Province, China. tsuiypa@helptx.com.cn
Key Words	Pneumonia; Human mesenchymal stem cells; Immunomodulation; Alveolar protection; Pandemic challenge & clinical trials
Core Tip	This article reviews the therapeutic potential and amplifiable merits of mesenchymal stem cells (MSCs) established over the past decade and summarize pioneering clinical progress of MSC-based strategies to treat lung diseases considering the current demands of the pandemic and future prospects.
Publish Date	2021-02-24 03:29
Citation	Lam G, Zhou Y, Wang JX, Tsui YP. Targeting mesenchymal stem cell therapy for severe pneumonia patients. World J Stem Cells 2021; 13(2):139-154
URL	https://www.wjgnet.com/1948-0210/full/v13/i2/139.htm
DOI	https://dx.doi.org/10.4252/wjsc.v13.i2.139

Full Article (PDF)	WJSC-13-139.pdf
Full Article (Word)	WJSC-13-139.docx
Manuscript File	58309_Auto_Edited.docx
Answering Reviewers	58309-Answering reviewers.pdf
Audio Core Tip	58309-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	58309-Conflict-of-interest statement.pdf
Copyright License Agreement	58309-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	58309-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	58309-Language certificate.pdf
Peer-review Report	58309-Peer-review(s).pdf
Scientific Misconduct Check	58309-Scientific misconduct check.pdf
Scientific Editor Work List	58309-Scientific editor work list.pdf
CrossCheck Report	58309-CrossCheck report.pdf